株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

バイオインフォマティクス:技術と世界市場

Bioinformatics: Technologies and Global Markets

発行 BCC Research 商品コード 268909
出版日 ページ情報 英文 219 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.75円で換算しております。
Back to Top
バイオインフォマティクス:技術と世界市場 Bioinformatics: Technologies and Global Markets
出版日: 2018年10月15日 ページ情報: 英文 219 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界のバイオインフォマティクス市場は、2017年の64億米ドルから、2022年までに160億米ドルまで拡大すると見られています。市場は、2017年〜2022年のCAGR (複合年間成長率) で、20.0%の成長が予測されています。

当レポートでは、世界のバイオインフォマティクス市場について調査分析し、市場概要、市場動向分析と予測、目標と役割、応用、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリーとハイライト

第3章 世界のバイオインフォマティクス市場:概要

  • バイオインフォマティクスの目標
    • 生物学的データソース
    • システム生物学におけるバイオインフォマティクス
    • 精密医療
    • 薬剤開発におけるバイオインフォマティクス
    • ケモインフォマティクス
    • 次世代シークエンシング
    • メタゲノミクス
    • データ管理システム
    • 市場動向
    • 精密医療とバイオマーカーの同定
    • クラウドベースソリューション
    • 価値ベースのケアへの移行
  • 市場課題
    • データ統合
    • データの信頼性と標準化
    • エンドツーエンドのワークフロー
  • 現在の市場
  • 市場:地域別
  • 市場:カテゴリー別
  • 公的資金
  • 民間資金
  • 市場:用途別

第4章 バイオインフォマティクス:データ生成とデータ管理

  • 情報オーバーロード
  • データ量
  • データの多様性
  • データの速度
  • データの正確度
  • ソフトウェアの拡張性と有効性
  • ビッグデータ世代の技術
  • NGSソフトウェアツールの急増
  • 機能ゲノミクス
  • プロテオミクスの進化
  • 糖鎖生物学の登場
  • RNAシークエンシング
  • メタボロミクスの進化
  • ケモインフォマティクスの進化
  • 新興技術
  • 薬理ゲノミクスの進化
  • iSAEC
  • 薬理ゲノミクスソフトウェア
  • トキシコゲノミクスの進化
  • トキシコゲノミクスのカスタマイズドプラットフォーム
  • データベース管理サービス
  • 市場力学

第5章 バイオインフォマティクス:データアナリティクスとソフトウェア

  • イントロダクション
  • データアナリティクスソフトウェア
  • バイオシミュレーションモデル
  • 市場分析

第6章 バイオインフォマティクス:データ処理とストレージ

  • ギャップへの配慮
  • 情報技術インフラ
  • 高性能コンピューティング
  • 高性能コンピュータークラスター
  • クラウドコンピューティング
  • DaaS
  • IaaS
  • PaaS
  • SaaS
  • SECaaS
  • クラウドコンピューティングの課題
  • クラウドコンピューティングの将来
  • 市場分析

第7章 バイオインフォマティクス:シークエンシングサービスとプラットフォーム

  • 市場分析
  • 市場セグメントの比較分析

第8章 バイオインフォマティクス:シークエンシングの応用

  • 市場分析

第9章 医薬品R&Dにおけるバイオインフォマティクスの応用

  • イントロダクション
  • 創薬と薬剤開発プロセス
  • 臨床研究:薬剤開発
  • 前臨床実験
  • ラボ情報管理システム
  • 電子ラボノート
  • 新薬申請のための調査
  • 臨床試験
  • 臨床試験設計・データ照合におけるバイオインフォマティクス
  • 新薬の申請
  • 新薬の承認
  • 上市後の継続的研究・第IV相臨床試験
  • EHR (電子医療記録)
  • モバイルヘルス技術
  • 結論

第10章 市場動向と分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スイス
  • アジア太平洋地域
    • インド
    • 中国
  • 結論

第11章 企業プロファイル

BCC Researchについて

図表

List of Tables

  • Summary Table: Global Bioinformatics Market, by Region, Through 2022
    • Table 1: PDB Data Distribution, by Experimental Method and Molecular Type
    • Table 2: RefSeq Accession Growth, 2016 and 2018
    • Table 3: Recommendations for NGS Bioinformatics Tools
    • Table 4: Leading Institutional Developers of Bioinformatics Tools, 2017
    • Table 5: Bioinformatics Tools Used for Metagenomics Analysis
    • Table 6: DBMS Platforms in Bioinformatics
    • Table 7: FDA and EMA Drug Approvals, 2012-2016
    • Table 8: Global Bioinformatics Market, by Region, Through 2022
    • Table 9: Public Funding Programs, by Country, 2012-2018
    • Table 10: Global Bioinformatics Market, by Category, Through 2022
    • Table 11: Global Bioinformatics Market, by Application, Through 2022
    • Table 12: Cloud-Based Bioinformatics Tools
    • Table 13: Commercially Available Metabolomic Software
    • Table 14: Open Access Tools for Complex Liquid Chromatography-Mass Spectrometry Data Analysis
    • Table 15: Cheminformatics Software Solutions for Drug R&D
    • Table 16: Bioinformatic Tools for Metagenomic Studies
    • Table 17: Pharmacogenomic Biomarkers in Drug Labeling
    • Table 18: Bioinformatics Tools and Databases Used in Pharmacogenomics
    • Table 19: Bioinformatic Tools for Pharmacogenomic Studies
    • Table 20: Bioinformatic Tools for Pharmacogenomic Software
    • Table 21: Toxicogenomic Studies Planned or Ongoing, 2016
    • Table 22: Archival Databases
    • Table 23: Curative Databases
    • Table 24: Commercially Available Databases
    • Table 25: Biological Databases for Human Research
    • Table 26: Software for Biological Analysis
    • Table 27: Open Source Bioinformatics Software
    • Table 28: NGS Platforms for Clinical Diagnostics
    • Table 29: Commonly Used Tools for NGS-based DNA Analysis, by Functional Category
    • Table 30: Commercially Available Integrated DNA Analysis Solutions and Relevant Functionality
    • Table 31: High-performance Computing Architectures: Advantages and Drawbacks
    • Table 32: Highest Performance Supercomputers, 2018
    • Table 33: SaaS Products
    • Table 34: Global Bioinformatics Market, by Sequencing Services and Platforms, Through 2022
    • Table 35: Sequence Analysis Software
    • Table 36: Sequence Alignment Platforms
    • Table 37: Global Bioinformatics Market, by Sequencing Application, Through 2022
    • Table 38: Sequencing Data Analysis Bioinformatics Software and Tools
    • Table 39: Bioinformatics-based Clinical and Medical Laboratory Information Management System
    • Table 40: Number of Medicines Developed Globally, 2017
    • Table 41: Bioinformatics Databases
    • Table 42: Leading Drug Target Databases
    • Table 43: Computer Simulation Platforms
    • Table 44: Leading LIMS Providers
    • Table 45: Key Suppliers of ELNs
    • Table 46: Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
    • Table 47: Drug R&D Process Overview
    • Table 48: Leading EHR Providers, 2018
    • Table 49: Medical Applications for Healthcare Professionals
    • Table 50: Pharmaceutical and Bioinformatic Partnerships and Alliances, 2015-2017
    • Table 51: North American Bioinformatics Market, by RegionCountry, Through 2022c
    • Table 52: Leading Bioinformatics Companies in the U.S.
    • Table 53: Venture Capital Companies Most Active in the Biotech Sector, 2015
    • Table 54: U.S. Bioinformatics Market, by Application, Through 2022
    • Table 55: U.S. Bioinformatics Market, by Category, Through 2022
    • Table 56: Canadian Bioinformatics Market, by Category, Through 2022
    • Table 57: Leading Canadian Bioinformatics Companies
    • Table 58: Canadian Bioinformatic Market, by Application, Through 2022
    • Table 59: European Bioinformatics Market, by Country, Through 2022
    • Table 60: Leading European Bioinformatics Companies
    • Table 61: U.K. Bioinformatics Market, by Category, Through 2022
    • Table 62: U.K. Bioinformatics Market, by Application, Through 2022
    • Table 63: Germany Bioinformatics Market, by Category, Through 2022
    • Table 64: Germany Bioinformatics Market, by Application, Through 2022
    • Table 65: Switzerland Bioinformatics Market, by Category, Through 2022
    • Table 66: Switzerland Bioinformatics Market, by Application, Through 2022
    • Table 67: Rest of European Bioinformatics Market, by Application, Through 2022
    • Table 68: Rest of Europeon Bioinformatics Market, by Category, Through 2022
    • Table 69: Asia-Pacific Bioinformatics Market, by Country, Through 2022
    • Table 70: Indian Bioinformatics Market, by Category, Through 2022
    • Table 71: Leading Indian Bioinformatics Companies
    • Table 72: Indian Bioinformatics Market, by Application, Through 2022
    • Table 73: China Bioinformatics Market, by Category, Through 2022
    • Table 74: China Bioinformatics Market, by Application, Through 2022
    • Table 75: Rest of Asia-Pacific Bioinformatics Market, by Application, Through 2022
    • Table 76: Rest of Asia-Pacific Bioinformatics Market, by Category, Through 2022
    • Table 77: Biomatters Ltd.: Product Portfolio
    • Table 78: Compugen Ltd.: Product Portfolio
    • Table 79: Dassault Systemes Biovia: Product Portfolio
    • Table 80: Dnastar, Inc.: Product Portfolio
    • Table 81: Dnastar, Inc.: Recent Developments, 2016
    • Table 82: Genedata AG: Product Portfolio
    • Table 83: Genedata AG: Recent Developments, 2017
    • Table 84: Geneva Bioformatics (Genebio) SA: Product Portfolio
    • Table 85: Genologics Lifesciences Software, Inc.: Product Portfolio
    • Table 86: Genomatix Software GMBH: Product Portfolio
    • Table 87: GNS Healthcare, Inc.: Product Portfolio
    • Table 88: GNS Healthcare, Inc.: Recent Developments, 2015-2017
    • Table 89: GVK Biosciences Private Ltd.: Product Portfolio
    • Table 90: GVK Biosciences Private Ltd: Recent Developments, 2017
    • Table 91: Inte:Ligand Software Entwicklungs Und Consulting Gmbh: Product Portfolio
    • Table 92: Illumina, Inc.: Product Portfolio
    • Table 93: Illumina, Inc.: Recent Developments, 2016-2017
    • Table 94: Macvector, Inc.: Product Portfolio
    • Table 95: Molecular Connections Private Ltd.: Product Portfolio
    • Table 96: Molecular Networks Gmbh: Product Portfolio
    • Table 97: Nonlinear Dynamics Ltd.: Product Portfolio
    • Table 98: Ocimum Biosolutions Ltd.: Product Portfolio
    • Table 99: Perkin Elmer Informatics, Inc.: Product Portfolio
    • Table 100: Personalis, Inc.: Product Portfolio
    • Table 101: Qlucore AB: Product Portfolio
    • Table 102: Qlucore AB: Recent Developments, 2018
    • Table 103: Real Time Genomics, Inc.: Product Portfolio
    • Table 104: Real Time Genomics, Inc.: Recent Developments, 2016
    • Table 105: Smartgene Services SARL: Product Portfolio
    • Table 106: Strand Life Sciences: Product Portfolio
    • Table 107: Strand Life Sciences: Recent Developments, 2017 and 2018
    • Table 108: Syngene International: Product Portfolio
    • Table 109: Syngene International: Recent Developments, 2016-2018

List of Figures

  • Summary Figure: Global Bioinformatics Market, by Region, 2016-2022
    • Figure 1: PDB Data Distribution, by Experimental Method and Molecular Type
    • Figure 2: RefSeq Accession Growth, 2016 and 2018
    • Figure 3: Relationship of Bioinformatics with Omic Technologies
    • Figure 4: Schematic Representation of Biology Systems and Translational Bioinformatics
    • Figure 5: Principles of Precision Medicine
    • Figure 6: Applications of Bioinformatics on Drug Development
    • Figure 7: Collaboration within the Bioinformatics Arena, by Country, 2016
    • Figure 8: Drug Approvals, by FDA's CDER, 2008-2018
    • Figure 9: Four Dimensions of Big Data
    • Figure 10: Software Scalability of Big Data Bioinformatics
    • Figure 11: Software Validation of Big Data Bioinformatics
    • Figure 12: Top-Down Proteomic Approach
    • Figure 13: European Bioinformatics Institute Software Solutions
    • Figure 14: Evolution of Information Technology Infrastructure
    • Figure 15: Schematic Representation of Cloud Computing Services
    • Figure 16: Global Bioinformatics Market Share, by Sequencing Services and Platforms, 2016 and 2022
    • Figure 17: Global Bioinformatics Market, by Sequencing Services, 2016-2022
    • Figure 18: Global Bioinformatics Market, by Sequencing Platform, 2016-2022
    • Figure 19: Clinical Bioinformatics for Patients for Precision Health
    • Figure 20: Number of Drugs Developed for Diseases, 2017
    • Figure 21: Classical and Digital Forensics with Respect to Bioinformatics
    • Figure 22: Drug Development Process
    • Figure 23: Phases in the Drug Discovery and Development Process
    • Figure 24: Phase Transition Success Rates and Likelihood of Approvals for All Modalities and Medicines, 2017
    • Figure 25: Steps in Drug Discovery
    • Figure 26: Information Systems within the Laboratory Architecture
    • Figure 27: Application of Bioinformatics in Clinical Trials
    • Figure 28: Key Areas of Research Utilizing Bioinformatics
目次
Product Code: BIO051D

Report Highlights:

The global market for bioinformatics should grow from $6.4 billion in 2017 to reach $16.0 billion by 2022 at a compound annual growth rate (CAGR) of 20.0% for the period of 2017-2022.

North American market for bioinformatics should grow from $3.5 billion in 2017 to reach $9.0 billion by 2022 at a CAGR of 21.0% for the period of 2017-2022.

Asia-Pacific market for bioinformatics should grow from $1.4 billion in 2017 to reach $3.6 billion by 2022 at a CAGR of 20.3% for the period of 2017-2022.

Report Scope:

The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industry to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.

Report Includes:

  • 28 data tables and 72 additional tables
  • An overview of the global market for bioinformatic technologies and their applications
  • Analyses of global market trends, with data from 2016, 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Discussion of the goal of bioinformatics and their role in systems biology
  • Insight into the application of bioinformatics on drug development, including cheminformatics, next-generation sequencing, metagenomics and data management systems
  • Detailed profiles of major companies in the market, including 3rd Millennium, Inc., Biomatters Ltd., Compugen Ltd., DNASTAR, Inc., and Illumina, Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Intended Audience
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

Chapter 3: Global Bioinformatics Market: Overview

  • Goal of Bioinformatics
    • Biological Data Sources
    • Bioinformatics in Systems Biology
    • Precision Medicine
    • Bioinformatics in Drug Development
    • Cheminformatics
    • Next-Generation Sequencing
    • Metagenomics
    • Database Management Systems
    • Market Trends
    • Precision Medicine and Biomarker Identification
    • Cloud-Based Solutions
    • Shift Toward Value-Based Care
  • Market Challenges
    • Data Integration
    • Data Reliability and Standardization
    • End-to-End Workflows
  • Current Market
  • Market by Region
  • Market by Category
  • Public Funding
  • Private Funding
  • Market by Application

Chapter 4: Bioinformatics: Data Generation and Data Management

  • Information Overload
  • Data Volume
  • Data Variety
  • Data Velocity
  • Data Veracity
  • Software Scalability and Validity
  • Technologies Behind Big Data Generation
    • Genomics
    • Sequencing Genomics
    • Metagenomics
  • Exponential Growth in NGS Software Tools
  • Functional Genomics
    • Functional Genomics in Drug Discovery
    • CRISPR Cas9 System
  • Proteomic Advances
    • Qualitative Proteomics
    • Quantitative Proteomics
    • Structural Proteomics
    • Advances in MS-Based Proteomics Technology for Exploring Triple Negative Breast Cancer
    • Investments in Structural Genomics and Open Science
    • Interaction Proteomics
    • Application in Drug Discovery
    • Bottom-Up Vs. Top-Down Proteomics
  • Emergence of Glycomics
    • Human Proteome Organization and Human Proteome Project Initiatives
    • Transcriptomic Advances
  • RNA Sequencing
    • Co-Expression and Single-Cell RNA-Seq
  • Metabolomic Advances
  • Advances in Cheminformatics
  • Emerging Technologies
    • Metagenomic Advances
    • Epigenomic Advances
  • Pharmacogenomic Advances
    • Pharmacogenomics and Precision Medicine
    • Value-Based Decisions
    • Pharmacogenomics and R&D
  • International Serious Adverse Events Consortium
  • Pharmacogenomic Software
  • Toxicogenomic Advances
  • Customized Toxicogenomic Platforms
  • Database Management Services
  • Market Dynamics

Chapter 5: Bioinformatics: Data Analysis and Software

  • Introduction
  • Data Analysis Software
  • Biosimulation Models
  • Market Analysis

Chapter 6: Bioinformatics: Data Processing and Storage

  • Mind the Gap
  • Information Technology Infrastructure
  • High-Performance Computing
  • High-Performance Computer Clusters
  • Cloud Computing
  • Data as a Service
  • Infrastructure as a Service
  • Platform as a Service
  • Software as a Service
  • Security as a Service
  • Cloud Computing Challenges
  • Future of Cloud Computing
  • Market Analysis

Chapter 7: Bioinformatics: Sequencing Services and Platforms

  • Market Analysis
  • Comparative Analysis Across Market Segments 2016 and 2022
    • Sequencing Services
    • Sequencing Platforms
    • Sequence Analysis Platforms
    • Sequence Alignment Platforms
    • Sequence Manipulation Platforms

Chapter 8: Bioinformatics: Sequencing Applications

  • Market Analysis
    • Agrigenomics
    • Clinical and Medical
    • Genealogy
    • Other Fields

Chapter 9: Bioinformatic Applications in Pharmaceutical R&D

  • Introduction
  • Drug Discovery and Development Process
    • Target Identification
    • Target Validation
    • Lead Identification
    • Lead Optimization
  • Clinical Research: Drug Development
  • Preclinical Experiments
  • Laboratory Information Management Systems
  • Electronic Laboratory Notebooks
  • Investigational New Drug Applications
  • Clinical Trials
  • Bioinformatics in Clinical Trial Design and Data Collation
  • New Drug Application
  • NDA Approval
  • Post-Launch Ongoing Studies and Phase IV Clinical Trials
  • Electronic Health Records
  • Mobile Health Technologies
    • Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
  • Conclusions

Chapter 10: Market Trends and Analysis

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Switzerland
  • Asia-Pacific
    • India
    • China
  • Conclusions

Chapter 11: Company Profiles

  • 3RD MILLENNIUM, INC.
  • BIOMATTERS LTD.
  • COMPUGEN LTD.
  • DASSAULT SYSTEMES BIOVIA
  • DNASTAR, INC.
  • GENEDATA AG
  • GENEVA BIOFORMATICS (GENEBIO) SA
  • GENOLOGICS LIFESCIENCES SOFTWARE, INC.
  • GENOMATIX SOFTWARE GMBH
  • GNS HEALTHCARE, INC.
  • GVK BIOSCIENCES PRIVATE LTD.
  • INTE:LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
  • ILLUMINA, INC.
  • MACVECTOR, INC.
  • MOLECULAR CONNECTIONS PRIVATE LTD.
  • MOLECULAR NETWORKS GMBH
  • NONLINEAR DYNAMICS LTD.
  • OCIMUM BIOSOLUTIONS LTD.
  • PERKIN ELMER INFORMATICS, INC.
  • PERSONALIS, INC.
  • QLUCORE AB
  • REAL TIME GENOMICS, INC.
  • SMARTGENE SERVICES SARL
  • STRAND LIFE SCIENCES
  • SYNGENE INTERNATIONAL
Back to Top